001     301271
005     20250819093032.0
024 7 _ |a 10.1093/hmg/ddaf059
|2 doi
024 7 _ |a pmid:40341939
|2 pmid
024 7 _ |a 0964-6906
|2 ISSN
024 7 _ |a 1460-2083
|2 ISSN
024 7 _ |a altmetric:176999153
|2 altmetric
037 _ _ |a DKFZ-2025-00956
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Byun, Jinyoung
|0 0000-0001-8579-1435
|b 0
245 _ _ |a Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci.
260 _ _ |a Oxford
|c 2025
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1755588594_6399
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Volume 34, Issue 14, 15 July 2025, Pages 1227–1237
520 _ _ |a Despite lung cancer affecting all races and ethnicities, disparities are observed in incidence and mortality rates among different ethnic groups in the United States. Non-Hispanic African Americans had a high incidence rate of lung cancer at 55.8 per 100 000 people, as well as the highest death rate at 37.2 per 100 000 people from 2016 to 2020. While previous genome-wide association studies (GWAS) have identified over 45 susceptibility risk loci that influence lung cancer development, few GWAS have investigated the etiology of lung cancer in African Americans. To address this gap in knowledge, we conducted GWAS of lung cancer focused on studying African Americans, comprising 2267 lung cancer cases and 4264 controls. We identified three loci associated with lung cancer, one with lung adenocarcinoma, and four with lung squamous cell carcinoma in this population at the genomic-wide significance level. Among them, three novel loci were identified near VWF at 12p13.31 for overall lung cancer and GACAT3 at 2p24.3 and LMAN1L at 15q24.1 for lung squamous cell carcinoma. In addition, we confirmed previously reported risk loci with known or new lead variants near CHRNA5 at 15q25.1 and CYP2A6 at 19q13.2 associated with lung cancer and TRIP13 at 5p15.33 and ERC1 at 12p13.33 associated with lung squamous cell carcinoma. Further multi-step functional analyses shed light on biological mechanisms underlying these associations of lung cancer in this population. Our study highlights the importance of ancestry-specific studies for the potential alleviation of lung cancer burden in African Americans.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a African American
|2 Other
650 _ 7 |a Genome-wide association study
|2 Other
650 _ 7 |a Lung cancer
|2 Other
650 _ 7 |a Polygenic risk score
|2 Other
650 _ 7 |a Post-GWAS
|2 Other
700 1 _ |a Han, Younghun
|b 1
700 1 _ |a Choi, Jiyeon
|0 0000-0002-0955-2384
|b 2
700 1 _ |a Sun, Ryan
|0 0000-0003-1176-1561
|b 3
700 1 _ |a Shaw, Vikram R
|0 0000-0002-1172-5686
|b 4
700 1 _ |a Zhu, Catherine
|0 0000-0002-4939-515X
|b 5
700 1 _ |a Xiao, Xiangjun
|b 6
700 1 _ |a Lusk, Christine
|b 7
700 1 _ |a Badr, Hoda
|0 0000-0002-4549-9111
|b 8
700 1 _ |a Lee, Hyun-Sung
|b 9
700 1 _ |a Jang, Hee-Jin
|b 10
700 1 _ |a Li, Yafang
|0 0000-0002-1333-1752
|b 11
700 1 _ |a Lim, Hyeyeun
|b 12
700 1 _ |a Long, Erping
|b 13
700 1 _ |a Liu, Yanhong
|b 14
700 1 _ |a Kachuri, Linda
|b 15
700 1 _ |a Walsh, Kyle M
|b 16
700 1 _ |a Wiencke, John K
|b 17
700 1 _ |a Albanes, Demetrius
|b 18
700 1 _ |a Lam, Stephen
|b 19
700 1 _ |a Tardon, Adonina
|b 20
700 1 _ |a Neuhouser, Marian L
|b 21
700 1 _ |a Barnett, Matt J
|b 22
700 1 _ |a Chen, Chu
|b 23
700 1 _ |a Bojesen, Stig
|b 24
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 25
|u dkfz
700 1 _ |a Landi, Maria Teresa
|b 26
700 1 _ |a Johansson, Mattias
|b 27
700 1 _ |a Risch, Angela
|0 P:(DE-He78)4981f4ef151aea881f38b33df8e35a21
|b 28
700 1 _ |a Wichmann, H-Erich
|b 29
700 1 _ |a Bickeböller, Heike
|b 30
700 1 _ |a Christiani, David C
|b 31
700 1 _ |a Rennert, Gad
|b 32
700 1 _ |a Arnold, Susanne
|b 33
700 1 _ |a Field, John K
|b 34
700 1 _ |a Shete, Sanjay
|0 0000-0001-7622-376X
|b 35
700 1 _ |a Le Marchand, Loic
|b 36
700 1 _ |a Liu, Geoffrey
|0 0000-0002-2603-7296
|b 37
700 1 _ |a Andrew, Angeline S
|b 38
700 1 _ |a Zienolddiny, Shanbeh
|b 39
700 1 _ |a Grankvist, Kjell
|b 40
700 1 _ |a Johansson, Mikael
|b 41
700 1 _ |a Caporaso, Neil
|b 42
700 1 _ |a Taylor, Fiona
|b 43
700 1 _ |a Lazarus, Philip
|b 44
700 1 _ |a Schabath, Matthew B
|0 0000-0003-3241-3216
|b 45
700 1 _ |a Aldrich, Melinda C
|0 0000-0003-3833-8448
|b 46
700 1 _ |a Patel, Alpa
|b 47
700 1 _ |a Lin, Xihong
|0 0000-0001-7067-7752
|b 48
700 1 _ |a Zanetti, Krista A
|b 49
700 1 _ |a Harris, Curtis C
|b 50
700 1 _ |a Chanock, Stephen
|b 51
700 1 _ |a McKay, James
|b 52
700 1 _ |a Schwartz, Ann G
|0 0000-0002-9525-1157
|b 53
700 1 _ |a Hung, Rayjean J
|b 54
700 1 _ |a Amos, Christopher I
|b 55
700 1 _ |a Consortium, INTEGRAL-ILCCO
|b 56
|e Collaboration Author
773 _ _ |a 10.1093/hmg/ddaf059
|g p. ddaf059
|0 PERI:(DE-600)1474816-2
|n 14
|p 1227–1237
|t Human molecular genetics
|v 34
|y 2025
|x 0964-6906
909 C O |p VDB
|o oai:inrepo02.dkfz.de:301271
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)4981f4ef151aea881f38b33df8e35a21
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HUM MOL GENET : 2022
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-01
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-01
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-01
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie der Krebsfrüherkennung
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Primäre Krebsprävention
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)B370-20160331
|k B370
|l Epigenomik
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)B370-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21